Adjuvant Therapy of Pegylated Interferon- 2b Plus Melanoma Peptide Vaccine
Clinical trial NCT00861406 · COMPLETED
Trial details
- NCT number
- NCT00861406
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-10
- Primary completion
- 2017-02-24
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.